These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17424937)

  • 1. Endogenous sphingolipid metabolites related to the growth in Sphingomonas chungbukensis.
    Burenjargal M; Lee YS; Yoo JM; Kim YC; Lee YM; Oh S; Yun YP; Hong JT; Chung YB; Moon DC; Yoo HS
    Arch Pharm Res; 2007 Mar; 30(3):317-22. PubMed ID: 17424937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of inhibitors of serine palmitoyltransferase (SPT), a key enzyme in sphingolipid biosynthesis, in intact cells. A novel evaluation system using an SPT-defective mammalian cell mutant.
    Hanada K; Nishijima M; Fujita T; Kobayashi S
    Biochem Pharmacol; 2000 May; 59(10):1211-6. PubMed ID: 10736421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
    Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
    Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption.
    Linn SC; Kim HS; Keane EM; Andras LM; Wang E; Merrill AH
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):831-5. PubMed ID: 11709083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal metabolite sulfamisterin suppresses sphingolipid synthesis through inhibition of serine palmitoyltransferase.
    Yamaji-Hasegawa A; Takahashi A; Tetsuka Y; Senoh Y; Kobayashi T
    Biochemistry; 2005 Jan; 44(1):268-77. PubMed ID: 15628868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for the de novo sphingolipids in apoptosis of photosensitized cells.
    Wispriyono B; Schmelz E; Pelayo H; Hanada K; Separovic D
    Exp Cell Res; 2002 Sep; 279(1):153-65. PubMed ID: 12213223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipid synthetic pathways are major regulators of lipid homeostasis.
    Worgall TS
    Adv Exp Med Biol; 2011; 721():139-48. PubMed ID: 21910087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
    Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
    Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and characterization of phosphoglucomutase and phosphomannomutase derived from Sphingomonas chungbukensis DJ77.
    Yoon SS; Park SH; Kim YC; Shin M; Chong CK; Choi JD
    J Biochem; 2008 Oct; 144(4):507-12. PubMed ID: 18664520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of Lagerstroemia speciosa on 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in HIT-T15 pancreatic β cells.
    Song JL; Zhao X; Wang Q; Zhang T
    Mol Med Rep; 2013 May; 7(5):1607-12. PubMed ID: 23545843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B1 and other structurally related compounds.
    van der Westhuizen L; Shephard GS; Snyman SD; Abel S; Swanevelder S; Gelderblom WC
    Food Chem Toxicol; 1998 Jun; 36(6):497-503. PubMed ID: 9674957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.
    Norris GH; Blesso CN
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29143791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
    Yoo HS; Norred WP; Showker J; Riley RT
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered de novo sphingolipid biosynthesis is involved in the serum deprivation-induced cell death in LLC-PK1 cells.
    Yu MU; Yoo JM; Lee YS; Lee YM; Hong JT; Oh KW; Song S; Yun YP; Yoo HS; Oh S
    J Toxicol Environ Health A; 2004 Dec; 67(23-24):2085-94. PubMed ID: 15513905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
    Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terpene alcohols inhibit de novo sphingolipid biosynthesis.
    Shin KO; Park MY; Seo CH; Lee YI; Kim HS; Yoo HS; Hong JT; Jung JK; Lee YM
    Planta Med; 2012 Mar; 78(5):434-9. PubMed ID: 22274813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo sphingolipid synthesis is essential for viability, but not for transport of glycosylphosphatidylinositol-anchored proteins, in African trypanosomes.
    Sutterwala SS; Creswell CH; Sanyal S; Menon AK; Bangs JD
    Eukaryot Cell; 2007 Mar; 6(3):454-64. PubMed ID: 17220466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles for de novo versus hydrolytic pathways of sphingolipid biosynthesis in Saccharomyces cerevisiae.
    Cowart LA; Okamoto Y; Lu X; Hannun YA
    Biochem J; 2006 Feb; 393(Pt 3):733-40. PubMed ID: 16201964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of diphenyl phthalate by Sphingomonas chungbukensis.
    Kim DS; Um HJ; Lim ES; Min J; Kim YH
    Biotechnol Lett; 2008 Jan; 30(1):93-6. PubMed ID: 17673949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.